Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Management of relapsed and refractory multiple myeloma: novel agents
Cancer Biol Ther
is a selective VEGFR1 inhibitor
On October 10
Formula: C8H10N2O4S
LEE011 succinate hydrate(1:1:x) Catalog No.:M9046-2 Management of relapsed and refractoryLEE011 succinate hydrate is an orally available cyclin dependent kinase (CDK) inhibitor targeting cyclin D1 CDK4 and cyclin D3 CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4 6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK mediated G1 S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing
US$ 45.00
US$ 68.00
US$ 55.00
US$ 68.00
US$ 38.00
US$ 38.00
US$ 65.00
US$ 125.00
US$ 165.00
US$ 18.00
US$ 54.40
US$ 38.00
US$ 28.00
US$ 38.00
US$ 75.00